Clinical Ink is the leading provider of eSource solutions for clinical trials. Clinical Ink’s SureSource™ platform is purpose-built to capture source data and documents electronically by investigator sites. Clinical Ink’s CentrosHealth™ platform is a patient-engagement tool designed to enable a suite of configurable educational and data capture solutions including protocol compliance, medication adherence, sensor integration, and much, much more. The combination of SureSource and CentrosHealth creates a world-class clinical trial technology platform differentiated by its ability to conduct truly ‘paperless’ clinical trials for pharma companies, research sites, and patients.
MPM joined Clinical Ink’s Board of Directors in March of 2015 as part of the Company’s Series C financing round. Simultaneously, Clinical Ink acquired CentrosHealth, an MPM-founded portfolio company